Evidence map›Paper›PMID 42057982›Full record

ArticleJournal of biomedical physics & engineering2026

Evaluating the Protective Effect of Melatonin on Apoptosis, Expression of Bax and Bcl2 Genes, and ROS Level after Radiofrequency Radiation on L929 Fibroblast Cell Line.

Reza Fardid, Fateme Zaker, Masoud Haghani, Jamileh Saberzadeh

Abstract read
In one paragraph

Article in Journal of biomedical physics & engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Reza FardidDepartment of Radiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Fateme ZakerDepartment of Radiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Masoud HaghaniDepartment of Radiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Jamileh SaberzadehDepartment of Laboratory Sciences, Paramedical School of Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The increasing use of mobile phones has raised concerns about potential health risks. In addition, the effect of protective materials is also important. Objective: This study aimed to evaluate the protective effect of Melatonin on cell viability, apoptosis, Reactive Oxygen Species (ROS) level, and gene expression of Bax and Bcl2 in L929 fibroblast cells after Radiofrequency (RF) radiation. Material and Methods: In this experimental study, cells were divided into six groups with at least 3 replications in each group. The two groups were respectively exposed to radiofrequency waves for 8 and 16 hours. They were pretreated with melatonin before radiation exposure, while the control group did not receive any radiation or melatonin during the experiment, and the melatonin group was just treated with melatonin. Results: Cell survival was reduced after 8 hours of RF radiation. After 16 hours, the total apoptosis was increased, and pretreatment with melatonin increased cell survival and reduced total apoptosis. Radiation increased intracellular ROS levels. RF increased the Bax/Bcl2 ratio, and the treatment with melatonin decreased it after 8 hours. Conclusion: Melatonin prevents the increase in apoptosis and Bax/Bcl2 ratio, but there are no significant changes in survival and ROS levels.

Indexed as

ApoptosisFibroblastsL929 CellsMelatoninRadiofrequency

Identifiers

PMID42057982
PMCPMC13122364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.